Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?

Author： Poredos Pavel   Jezovnik Mateja Kaja  

Publisher： MDPI

E-ISSN： 1422-0067|16|7|14477-14489

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.16, Iss.7, 2015-06, pp. : 14477-14489

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients

By Ito Shunsuke   Yoshida Masayuki  

Toxins, Vol. 6, Iss. 2, 2014-02 ,pp. : 665-678

MDPI

Access to resources Recommend Favorite

Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease

By Weng Yunqi   Yao Jian   Sparks Sawyer   Wang Kevin Yueju  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-02 ,pp. : 523-523

MDPI

Access to resources Recommend Favorite

Chlamydia pneumoniae and Oxidative Stress in Cardiovascular Disease: State of the Art and Prevention Strategies

By Di Pietro Marisa   Filardo Simone   De Santis Fiorenzo   Mastromarino Paola   Sessa Rosa  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2014-12 ,pp. : 724-735

MDPI

Access to resources Recommend Favorite

Dairy Fats and Cardiovascular Disease: Do We Really Need to Be Concerned?

By Lordan Ronan   Tsoupras Alexandros   Mitra Bhaskar   Zabetakis Ioannis  

Foods, Vol. 7, Iss. 3, 2018-03 ,pp. : 29-29

MDPI

Access to resources Recommend Favorite

Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease

By Steven Sebastian   Münzel Thomas   Daiber Andreas  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 18185-18223

MDPI

Access to resources Recommend Favorite